{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Guide to Pharmacology - COVID19 release"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "I believe more information from guide to Pharmacology can be integrated, but the least that can be done is integrating their IDs in Wikidata."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Ligands"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ligand (Therapeutic)</th>\n",
       "      <th>qid</th>\n",
       "      <th>Ligand ID</th>\n",
       "      <th>Comments</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ACE2 ligands</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACE2 ligands that block the site of viral spik...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>anakinra</td>\n",
       "      <td>Q415411</td>\n",
       "      <td>6972.0</td>\n",
       "      <td>An approved IL-1 pathway blocking peptide, tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ASC09F</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A combination drug containing ASC09 (a viral p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Baricitinib</td>\n",
       "      <td>Q4860707</td>\n",
       "      <td>7792.0</td>\n",
       "      <td>Approved JAK1/2 inhibitor. AI predicts antivir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>beta-D-N4-hydroxycytidine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10735.0</td>\n",
       "      <td>Preliminary evidence from a BioRxiv preprint (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Q413299</td>\n",
       "      <td>6771.0</td>\n",
       "      <td>Approved anti-VEGFA mAb. Phase 2/3 NCT04275414...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>brincidofovir</td>\n",
       "      <td>Q15411004</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Small-molecule nucleoside analogue antiviral d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>camostat</td>\n",
       "      <td>Q5026909</td>\n",
       "      <td>6432.0</td>\n",
       "      <td>Serine protease inhibitor with activity agains...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Camrelizumab</td>\n",
       "      <td>Q60785565</td>\n",
       "      <td>9758.0</td>\n",
       "      <td>An anti-PD-1 checkpoiunt inhibitor approved in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>compound 11r</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10706.0</td>\n",
       "      <td>This is a compound that inhibits the SARS-CoV ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>compound 13b</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10720.0</td>\n",
       "      <td>A more drug-like derivative of 11r (10706) tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>cobicistat</td>\n",
       "      <td>Q5138908</td>\n",
       "      <td>7535.0</td>\n",
       "      <td>darunavir: Antiretroviral, protease inhibitor....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>eculizumab</td>\n",
       "      <td>Q421617</td>\n",
       "      <td>6884.0</td>\n",
       "      <td>Approved mAb that binds complement factor C5 a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>emapalumab</td>\n",
       "      <td>Q28209889</td>\n",
       "      <td>9295.0</td>\n",
       "      <td>An approved anti-IFN_ mAb, which could target ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Tenofovir/emtricitabine</td>\n",
       "      <td>Q2412859</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NRTI/NtRTI anti-HIV combination that could be ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>enoxaparin</td>\n",
       "      <td>Q416516</td>\n",
       "      <td>6811.0</td>\n",
       "      <td>An approved anti-clotting agent. Given evidenc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>favipiravir</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Small-molecule nucleoside analogue antiviral d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>fingolimod</td>\n",
       "      <td>Q425137</td>\n",
       "      <td>2407.0</td>\n",
       "      <td>An approved S1P1 receptor inhibitor that has i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Galidesivir</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Viral RNA-dependent RNA polymerase inhibitor t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>GLS-5300</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1 MERS vaccine.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Q421094</td>\n",
       "      <td>7198.0</td>\n",
       "      <td>An existing antimalarial drug, with in vitro a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>I-432</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10733.0</td>\n",
       "      <td>An in vitro tool compound; inhibitor of serine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>meplazumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An anti-CD147 (basigin, BSG) mAb. SARS-CoV-2 m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>mucolytic drugs</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10692.0</td>\n",
       "      <td>Ambroxol is an approved mucolytic which has th...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>otamixaban</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10732.0</td>\n",
       "      <td>A direct serine protease factor Xa inhibitor, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>PRD_002214</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10716.0</td>\n",
       "      <td>PRD_002214 is a viral main protease inhibitor....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>recombinant ACE2 protein (rhACE2)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NCT04287686 aims to determine if rhACE2 can ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>recombinant coronavirus S (spike) protein</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Recombinant spike protein would be predicted t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>recombinant human Type I  interferons</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>For example IFNalpha2a (Roferon A), IFNalpha2a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>REGN3051 and REGN3048</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A mixture of monoclonal antibodies that target...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>relacatib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7862.0</td>\n",
       "      <td>Developed as a cathepsin K inhibitor but has a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>remdesivir</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10715.0</td>\n",
       "      <td>Nucleotide analogue antiviral with broad-spect...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>chloroquine</td>\n",
       "      <td>Q422438</td>\n",
       "      <td>5535.0</td>\n",
       "      <td>with remdesivir. Effectively inhibits a clinic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>ribavirin</td>\n",
       "      <td>Q421862</td>\n",
       "      <td>6842.0</td>\n",
       "      <td>with ritonavir. Anti-HIV combination that coul...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>ritonavir</td>\n",
       "      <td>Q422618</td>\n",
       "      <td>8804.0</td>\n",
       "      <td>NCT04295551. Update: No significant benefit fr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>ruxolitinib</td>\n",
       "      <td>Q7383611</td>\n",
       "      <td>5688.0</td>\n",
       "      <td>An approved anti-inflammatory JAK1/2/TYK2 inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Sarilumab</td>\n",
       "      <td>Q7424081</td>\n",
       "      <td>7999.0</td>\n",
       "      <td>Approved immunosuppressive anti-IL-6 receptor ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>sirolimus</td>\n",
       "      <td>Q32089</td>\n",
       "      <td>6031.0</td>\n",
       "      <td>An approved immunosuppressive drug. Sirolimus ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>thalidomide</td>\n",
       "      <td>Q203174</td>\n",
       "      <td>7327.0</td>\n",
       "      <td>Thalidomide + low-dose glucocorticoid, and tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Q425154</td>\n",
       "      <td>6881.0</td>\n",
       "      <td>Approved immunosuppressive anti-IL-6 receptor ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Ciclesonide</td>\n",
       "      <td>Q5119448</td>\n",
       "      <td>7469.0</td>\n",
       "      <td>Ciclesonide (an approved corticosteroid used t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>umifenovir</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A broad-spectrum antiviral drug used to treat ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                         Ligand (Therapeutic)        qid  Ligand ID  \\\n",
       "0                                ACE2 ligands        NaN        NaN   \n",
       "1                                    anakinra    Q415411     6972.0   \n",
       "2                                      ASC09F        NaN        NaN   \n",
       "3                                 Baricitinib   Q4860707     7792.0   \n",
       "4                   beta-D-N4-hydroxycytidine        NaN    10735.0   \n",
       "5                                 bevacizumab    Q413299     6771.0   \n",
       "6                               brincidofovir  Q15411004        NaN   \n",
       "7                                    camostat   Q5026909     6432.0   \n",
       "8                                Camrelizumab  Q60785565     9758.0   \n",
       "9                                compound 11r        NaN    10706.0   \n",
       "10                               compound 13b        NaN    10720.0   \n",
       "11                                 cobicistat   Q5138908     7535.0   \n",
       "12                                 eculizumab    Q421617     6884.0   \n",
       "13                                 emapalumab  Q28209889     9295.0   \n",
       "14                    Tenofovir/emtricitabine   Q2412859        NaN   \n",
       "15                                 enoxaparin    Q416516     6811.0   \n",
       "16                                favipiravir        NaN        NaN   \n",
       "17                                 fingolimod    Q425137     2407.0   \n",
       "18                                Galidesivir        NaN        NaN   \n",
       "19                                   GLS-5300        NaN        NaN   \n",
       "20                         hydroxychloroquine    Q421094     7198.0   \n",
       "21                                      I-432        NaN    10733.0   \n",
       "22                                 meplazumab        NaN        NaN   \n",
       "23                            mucolytic drugs        NaN    10692.0   \n",
       "24                                 otamixaban        NaN    10732.0   \n",
       "25                                 PRD_002214        NaN    10716.0   \n",
       "26          recombinant ACE2 protein (rhACE2)        NaN        NaN   \n",
       "27  recombinant coronavirus S (spike) protein        NaN        NaN   \n",
       "28      recombinant human Type I  interferons        NaN        NaN   \n",
       "29                      REGN3051 and REGN3048        NaN        NaN   \n",
       "30                                  relacatib        NaN     7862.0   \n",
       "31                                 remdesivir        NaN    10715.0   \n",
       "32                                chloroquine    Q422438     5535.0   \n",
       "33                                  ribavirin    Q421862     6842.0   \n",
       "34                                  ritonavir    Q422618     8804.0   \n",
       "35                                ruxolitinib   Q7383611     5688.0   \n",
       "36                                  Sarilumab   Q7424081     7999.0   \n",
       "37                                  sirolimus     Q32089     6031.0   \n",
       "38                                thalidomide    Q203174     7327.0   \n",
       "39                                tocilizumab    Q425154     6881.0   \n",
       "40                                Ciclesonide   Q5119448     7469.0   \n",
       "41                                 umifenovir        NaN        NaN   \n",
       "\n",
       "                                             Comments  \n",
       "0   ACE2 ligands that block the site of viral spik...  \n",
       "1   An approved IL-1 pathway blocking peptide, tha...  \n",
       "2   A combination drug containing ASC09 (a viral p...  \n",
       "3   Approved JAK1/2 inhibitor. AI predicts antivir...  \n",
       "4   Preliminary evidence from a BioRxiv preprint (...  \n",
       "5   Approved anti-VEGFA mAb. Phase 2/3 NCT04275414...  \n",
       "6   Small-molecule nucleoside analogue antiviral d...  \n",
       "7   Serine protease inhibitor with activity agains...  \n",
       "8   An anti-PD-1 checkpoiunt inhibitor approved in...  \n",
       "9   This is a compound that inhibits the SARS-CoV ...  \n",
       "10  A more drug-like derivative of 11r (10706) tha...  \n",
       "11  darunavir: Antiretroviral, protease inhibitor....  \n",
       "12  Approved mAb that binds complement factor C5 a...  \n",
       "13  An approved anti-IFN_ mAb, which could target ...  \n",
       "14  NRTI/NtRTI anti-HIV combination that could be ...  \n",
       "15  An approved anti-clotting agent. Given evidenc...  \n",
       "16  Small-molecule nucleoside analogue antiviral d...  \n",
       "17  An approved S1P1 receptor inhibitor that has i...  \n",
       "18  Viral RNA-dependent RNA polymerase inhibitor t...  \n",
       "19                            A Phase 1 MERS vaccine.  \n",
       "20  An existing antimalarial drug, with in vitro a...  \n",
       "21  An in vitro tool compound; inhibitor of serine...  \n",
       "22  An anti-CD147 (basigin, BSG) mAb. SARS-CoV-2 m...  \n",
       "23  Ambroxol is an approved mucolytic which has th...  \n",
       "24  A direct serine protease factor Xa inhibitor, ...  \n",
       "25  PRD_002214 is a viral main protease inhibitor....  \n",
       "26  NCT04287686 aims to determine if rhACE2 can ac...  \n",
       "27  Recombinant spike protein would be predicted t...  \n",
       "28  For example IFNalpha2a (Roferon A), IFNalpha2a...  \n",
       "29  A mixture of monoclonal antibodies that target...  \n",
       "30  Developed as a cathepsin K inhibitor but has a...  \n",
       "31  Nucleotide analogue antiviral with broad-spect...  \n",
       "32  with remdesivir. Effectively inhibits a clinic...  \n",
       "33  with ritonavir. Anti-HIV combination that coul...  \n",
       "34  NCT04295551. Update: No significant benefit fr...  \n",
       "35  An approved anti-inflammatory JAK1/2/TYK2 inhi...  \n",
       "36  Approved immunosuppressive anti-IL-6 receptor ...  \n",
       "37  An approved immunosuppressive drug. Sirolimus ...  \n",
       "38  Thalidomide + low-dose glucocorticoid, and tha...  \n",
       "39  Approved immunosuppressive anti-IL-6 receptor ...  \n",
       "40  Ciclesonide (an approved corticosteroid used t...  \n",
       "41  A broad-spectrum antiviral drug used to treat ...  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "covid_ligands = pd.read_csv(\"./gtopdb_ligands_reconciled.csv\")\n",
    "covid_ligands"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Ligand (Therapeutic)</th>\n",
       "      <th>qid</th>\n",
       "      <th>Ligand ID</th>\n",
       "      <th>Comments</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>anakinra</td>\n",
       "      <td>Q415411</td>\n",
       "      <td>6972.0</td>\n",
       "      <td>An approved IL-1 pathway blocking peptide, tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Baricitinib</td>\n",
       "      <td>Q4860707</td>\n",
       "      <td>7792.0</td>\n",
       "      <td>Approved JAK1/2 inhibitor. AI predicts antivir...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Q413299</td>\n",
       "      <td>6771.0</td>\n",
       "      <td>Approved anti-VEGFA mAb. Phase 2/3 NCT04275414...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>camostat</td>\n",
       "      <td>Q5026909</td>\n",
       "      <td>6432.0</td>\n",
       "      <td>Serine protease inhibitor with activity agains...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Camrelizumab</td>\n",
       "      <td>Q60785565</td>\n",
       "      <td>9758.0</td>\n",
       "      <td>An anti-PD-1 checkpoiunt inhibitor approved in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>cobicistat</td>\n",
       "      <td>Q5138908</td>\n",
       "      <td>7535.0</td>\n",
       "      <td>darunavir: Antiretroviral, protease inhibitor....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>eculizumab</td>\n",
       "      <td>Q421617</td>\n",
       "      <td>6884.0</td>\n",
       "      <td>Approved mAb that binds complement factor C5 a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>emapalumab</td>\n",
       "      <td>Q28209889</td>\n",
       "      <td>9295.0</td>\n",
       "      <td>An approved anti-IFN_ mAb, which could target ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>enoxaparin</td>\n",
       "      <td>Q416516</td>\n",
       "      <td>6811.0</td>\n",
       "      <td>An approved anti-clotting agent. Given evidenc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>fingolimod</td>\n",
       "      <td>Q425137</td>\n",
       "      <td>2407.0</td>\n",
       "      <td>An approved S1P1 receptor inhibitor that has i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Q421094</td>\n",
       "      <td>7198.0</td>\n",
       "      <td>An existing antimalarial drug, with in vitro a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>chloroquine</td>\n",
       "      <td>Q422438</td>\n",
       "      <td>5535.0</td>\n",
       "      <td>with remdesivir. Effectively inhibits a clinic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>ribavirin</td>\n",
       "      <td>Q421862</td>\n",
       "      <td>6842.0</td>\n",
       "      <td>with ritonavir. Anti-HIV combination that coul...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>ritonavir</td>\n",
       "      <td>Q422618</td>\n",
       "      <td>8804.0</td>\n",
       "      <td>NCT04295551. Update: No significant benefit fr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>ruxolitinib</td>\n",
       "      <td>Q7383611</td>\n",
       "      <td>5688.0</td>\n",
       "      <td>An approved anti-inflammatory JAK1/2/TYK2 inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Sarilumab</td>\n",
       "      <td>Q7424081</td>\n",
       "      <td>7999.0</td>\n",
       "      <td>Approved immunosuppressive anti-IL-6 receptor ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>sirolimus</td>\n",
       "      <td>Q32089</td>\n",
       "      <td>6031.0</td>\n",
       "      <td>An approved immunosuppressive drug. Sirolimus ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>thalidomide</td>\n",
       "      <td>Q203174</td>\n",
       "      <td>7327.0</td>\n",
       "      <td>Thalidomide + low-dose glucocorticoid, and tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Q425154</td>\n",
       "      <td>6881.0</td>\n",
       "      <td>Approved immunosuppressive anti-IL-6 receptor ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Ciclesonide</td>\n",
       "      <td>Q5119448</td>\n",
       "      <td>7469.0</td>\n",
       "      <td>Ciclesonide (an approved corticosteroid used t...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Ligand (Therapeutic)        qid  Ligand ID  \\\n",
       "1              anakinra    Q415411     6972.0   \n",
       "3           Baricitinib   Q4860707     7792.0   \n",
       "5           bevacizumab    Q413299     6771.0   \n",
       "7              camostat   Q5026909     6432.0   \n",
       "8          Camrelizumab  Q60785565     9758.0   \n",
       "11           cobicistat   Q5138908     7535.0   \n",
       "12           eculizumab    Q421617     6884.0   \n",
       "13           emapalumab  Q28209889     9295.0   \n",
       "15           enoxaparin    Q416516     6811.0   \n",
       "17           fingolimod    Q425137     2407.0   \n",
       "20   hydroxychloroquine    Q421094     7198.0   \n",
       "32          chloroquine    Q422438     5535.0   \n",
       "33            ribavirin    Q421862     6842.0   \n",
       "34            ritonavir    Q422618     8804.0   \n",
       "35          ruxolitinib   Q7383611     5688.0   \n",
       "36            Sarilumab   Q7424081     7999.0   \n",
       "37            sirolimus     Q32089     6031.0   \n",
       "38          thalidomide    Q203174     7327.0   \n",
       "39          tocilizumab    Q425154     6881.0   \n",
       "40          Ciclesonide   Q5119448     7469.0   \n",
       "\n",
       "                                             Comments  \n",
       "1   An approved IL-1 pathway blocking peptide, tha...  \n",
       "3   Approved JAK1/2 inhibitor. AI predicts antivir...  \n",
       "5   Approved anti-VEGFA mAb. Phase 2/3 NCT04275414...  \n",
       "7   Serine protease inhibitor with activity agains...  \n",
       "8   An anti-PD-1 checkpoiunt inhibitor approved in...  \n",
       "11  darunavir: Antiretroviral, protease inhibitor....  \n",
       "12  Approved mAb that binds complement factor C5 a...  \n",
       "13  An approved anti-IFN_ mAb, which could target ...  \n",
       "15  An approved anti-clotting agent. Given evidenc...  \n",
       "17  An approved S1P1 receptor inhibitor that has i...  \n",
       "20  An existing antimalarial drug, with in vitro a...  \n",
       "32  with remdesivir. Effectively inhibits a clinic...  \n",
       "33  with ritonavir. Anti-HIV combination that coul...  \n",
       "34  NCT04295551. Update: No significant benefit fr...  \n",
       "35  An approved anti-inflammatory JAK1/2/TYK2 inhi...  \n",
       "36  Approved immunosuppressive anti-IL-6 receptor ...  \n",
       "37  An approved immunosuppressive drug. Sirolimus ...  \n",
       "38  Thalidomide + low-dose glucocorticoid, and tha...  \n",
       "39  Approved immunosuppressive anti-IL-6 receptor ...  \n",
       "40  Ciclesonide (an approved corticosteroid used t...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "has_qid = covid_ligands.query(\"qid.notnull() & `Ligand ID`.notnull()\")\n",
    "has_qid"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q415411|P595|\"6972\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q4860707|P595|\"7792\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q413299|P595|\"6771\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q5026909|P595|\"6432\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q60785565|P595|\"9758\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q5138908|P595|\"7535\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q421617|P595|\"6884\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q28209889|P595|\"9295\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q416516|P595|\"6811\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q425137|P595|\"2407\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q421094|P595|\"7198\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q422438|P595|\"5535\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q421862|P595|\"6842\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q422618|P595|\"8804\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q7383611|P595|\"5688\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q7424081|P595|\"7999\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q32089|P595|\"6031\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q203174|P595|\"7327\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q425154|P595|\"6881\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q5119448|P595|\"7469\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n"
     ]
    }
   ],
   "source": [
    "for index,row in has_qid.iterrows():\n",
    "    ligand_id = str(int(row['Ligand ID']))\n",
    "    print(\n",
    "    row['qid'] + \"|P595|\" + '\"' + ligand_id + '\"' + \"|S854|\" + '\"' + \n",
    "        'https://www.guidetopharmacology.org/coronavirus.jsp' + '\"' +\n",
    "        \"|S813|\" + \"+2020-04-22T00:00:00Z/11\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Targets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Target</th>\n",
       "      <th>qid</th>\n",
       "      <th>Target ID</th>\n",
       "      <th>Comments</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Angiotensin I converting enzyme 2</td>\n",
       "      <td>Q301630</td>\n",
       "      <td>1614.0</td>\n",
       "      <td>Receptor on host cells that is exploited by so...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Transmembrane serine protease 2</td>\n",
       "      <td>Q21126599</td>\n",
       "      <td>2421.0</td>\n",
       "      <td>Involved in the activation of viral glycoprote...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>non-structural protein 5 [SARS-CoV-2]</td>\n",
       "      <td>Q87917582</td>\n",
       "      <td>3111.0</td>\n",
       "      <td>Inhibitors of this viral protease have the pot...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CD147 (basigin, HGNC:1116)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>SARS-CoV-2 may utilise CD147 as an additional ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  Target        qid  Target ID  \\\n",
       "0      Angiotensin I converting enzyme 2    Q301630     1614.0   \n",
       "1        Transmembrane serine protease 2  Q21126599     2421.0   \n",
       "2  non-structural protein 5 [SARS-CoV-2]  Q87917582     3111.0   \n",
       "3            CD147 (basigin, HGNC:1116)         NaN        NaN   \n",
       "\n",
       "                                            Comments  \n",
       "0  Receptor on host cells that is exploited by so...  \n",
       "1  Involved in the activation of viral glycoprote...  \n",
       "2  Inhibitors of this viral protease have the pot...  \n",
       "3  SARS-CoV-2 may utilise CD147 as an additional ...  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "covid_targets = pd.read_csv(\"./gtopdb_targets_reconciled.csv\")\n",
    "covid_targets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "covid_targets.dropna(inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q301630|P5458|\"1614\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q21126599|P5458|\"2421\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n",
      "Q87917582|P5458|\"3111\"|S854|\"https://www.guidetopharmacology.org/coronavirus.jsp\"|S813|+2020-04-22T00:00:00Z/11\n"
     ]
    }
   ],
   "source": [
    "for index,row in covid_targets.iterrows():\n",
    "    target_id = str(int(row['Target ID']))\n",
    "    print(\n",
    "    row['qid'] + \"|P5458|\" + '\"' + target_id + '\"' + \"|S854|\" + '\"' + \n",
    "        'https://www.guidetopharmacology.org/coronavirus.jsp' + '\"' +\n",
    "        \"|S813|\" + \"+2020-04-22T00:00:00Z/11\"\n",
    "    )"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
